Guanoxabenz: Difference between revisions
m Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
m Protected "Guanoxabenz": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)) |
||
| (2 intermediate revisions by one other user not shown) | |||
| Line 25: | Line 25: | ||
}} | }} | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | {{CMG}} | ||
==Overview== | |||
'''Guanoxabenz''' is a metabolite of [[guanabenz]]. | '''Guanoxabenz''' is a metabolite of [[guanabenz]]. | ||
==References== | |||
{{reflist|2}} | |||
{{Adrenergic agonists}} | {{Adrenergic agonists}} | ||
[[Category:Antihypertensive agents]] | |||
[[Category:Cardiovascular Drugs]] | |||
[[Category:Drug]] | |||
Latest revision as of 16:27, 20 August 2015
|
WikiDoc Resources for Guanoxabenz |
|
Articles |
|---|
|
Most recent articles on Guanoxabenz Most cited articles on Guanoxabenz |
|
Media |
|
Powerpoint slides on Guanoxabenz |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Guanoxabenz at Clinical Trials.gov Clinical Trials on Guanoxabenz at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Guanoxabenz
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Guanoxabenz Discussion groups on Guanoxabenz Patient Handouts on Guanoxabenz Directions to Hospitals Treating Guanoxabenz Risk calculators and risk factors for Guanoxabenz
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Guanoxabenz |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Guanoxabenz is a metabolite of guanabenz.